 | • レポートコード：QYR2104Z4960 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、組換えタンパク質のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン、成長因子、サイトカイン、血漿タンパク質因子、組換え代謝酵素、免疫チェックポイント阻害剤、その他）、用途別市場規模（バイオ医薬品企業、学術研究機関、委託研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・組換えタンパク質の市場動向 ・企業の競争状況、市場シェア ・組換えタンパク質の種類別市場規模（ホルモン、成長因子、サイトカイン、血漿タンパク質因子、組換え代謝酵素、免疫チェックポイント阻害剤、その他） ・組換えタンパク質の用途別市場規模（バイオ医薬品企業、学術研究機関、委託研究機関） ・組換えタンパク質の北米市場規模2016-2027（アメリカ、カナダ） ・組換えタンパク質のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・組換えタンパク質のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・組換えタンパク質の中南米市場規模2016-2027（メキシコ、ブラジル） ・組換えタンパク質の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abcam PLC、R&D Systems、Miltenyi Biotec、Thermo Fisher Scientific、Sigma Aldrich Company、GE Healthcare、Lonza、Merck KGaA、ProSpec Tany TechnoGene、Eurogentec (Kaneka Corporation)、PeproTech、BPS Bioscience、Reprocell、GenScript Biotech Corporation、Abnova Corporation） ・結論 |
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Abcam PLC was the largest company in the global Recombinant Proteins market, with a revenue market share of 13% in 2018.
Top 5 companies occupied 40% of the market.
By region, Europe was the biggest region, with a revenue market share over 33%, and North America ranked 2. Asia-Pacific ranked 3, and its market grew fastest.
Market Analysis and Insights: Global Recombinant Proteins Market
The global Recombinant Proteins market size is projected to reach US$ 1062 million by 2026, from US$ 612 million in 2019, at a CAGR of 8.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Proteins market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Proteins market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Proteins market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Proteins market.
Global Recombinant Proteins Scope and Market Size
Recombinant Proteins market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Proteins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Hormones and Cytokines were the two largest segments of Recombinant Protein in global market, with market shares of 26% and 22% respectively in 2018.
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Recombinant Protein was used in Biopharmaceutical Companies widest, with a proportion of 62% in 2018.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Thermo Fisher Scientific
Sigma Aldrich Company
BPS Bioscience
Reprocell
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Proteins Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Proteins Market Perspective (2016-2027)
2.2 Recombinant Proteins Growth Trends by Regions
2.2.1 Recombinant Proteins Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recombinant Proteins Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant Proteins Forecasted Market Size by Regions (2022-2027)
2.3 Recombinant Proteins Industry Dynamic
2.3.1 Recombinant Proteins Market Trends
2.3.2 Recombinant Proteins Market Drivers
2.3.3 Recombinant Proteins Market Challenges
2.3.4 Recombinant Proteins Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Proteins Players by Revenue
3.1.1 Global Top Recombinant Proteins Players by Revenue (2016-2021)
3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2016-2021)
3.2 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recombinant Proteins Revenue
3.4 Global Recombinant Proteins Market Concentration Ratio
3.4.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2020
3.5 Recombinant Proteins Key Players Head office and Area Served
3.6 Key Players Recombinant Proteins Product Solution and Service
3.7 Date of Enter into Recombinant Proteins Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Proteins Breakdown Data by Type
4.1 Global Recombinant Proteins Historic Market Size by Type (2016-2021)
4.2 Global Recombinant Proteins Forecasted Market Size by Type (2022-2027)
5 Recombinant Proteins Breakdown Data by Application
5.1 Global Recombinant Proteins Historic Market Size by Application (2016-2021)
5.2 Global Recombinant Proteins Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Recombinant Proteins Market Size (2016-2027)
6.2 North America Recombinant Proteins Market Size by Type
6.2.1 North America Recombinant Proteins Market Size by Type (2016-2021)
6.2.2 North America Recombinant Proteins Market Size by Type (2022-2027)
6.2.3 North America Recombinant Proteins Market Size by Type (2016-2027)
6.3 North America Recombinant Proteins Market Size by Application
6.3.1 North America Recombinant Proteins Market Size by Application (2016-2021)
6.3.2 North America Recombinant Proteins Market Size by Application (2022-2027)
6.3.3 North America Recombinant Proteins Market Size by Application (2016-2027)
6.4 North America Recombinant Proteins Market Size by Country
6.4.1 North America Recombinant Proteins Market Size by Country (2016-2021)
6.4.2 North America Recombinant Proteins Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Recombinant Proteins Market Size (2016-2027)
7.2 Europe Recombinant Proteins Market Size by Type
7.2.1 Europe Recombinant Proteins Market Size by Type (2016-2021)
7.2.2 Europe Recombinant Proteins Market Size by Type (2022-2027)
7.2.3 Europe Recombinant Proteins Market Size by Type (2016-2027)
7.3 Europe Recombinant Proteins Market Size by Application
7.3.1 Europe Recombinant Proteins Market Size by Application (2016-2021)
7.3.2 Europe Recombinant Proteins Market Size by Application (2022-2027)
7.3.3 Europe Recombinant Proteins Market Size by Application (2016-2027)
7.4 Europe Recombinant Proteins Market Size by Country
7.4.1 Europe Recombinant Proteins Market Size by Country (2016-2021)
7.4.2 Europe Recombinant Proteins Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Proteins Market Size (2016-2027)
8.2 Asia-Pacific Recombinant Proteins Market Size by Type
8.2.1 Asia-Pacific Recombinant Proteins Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recombinant Proteins Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recombinant Proteins Market Size by Type (2016-2027)
8.3 Asia-Pacific Recombinant Proteins Market Size by Application
8.3.1 Asia-Pacific Recombinant Proteins Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recombinant Proteins Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recombinant Proteins Market Size by Application (2016-2027)
8.4 Asia-Pacific Recombinant Proteins Market Size by Region
8.4.1 Asia-Pacific Recombinant Proteins Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recombinant Proteins Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recombinant Proteins Market Size (2016-2027)
9.2 Latin America Recombinant Proteins Market Size by Type
9.2.1 Latin America Recombinant Proteins Market Size by Type (2016-2021)
9.2.2 Latin America Recombinant Proteins Market Size by Type (2022-2027)
9.2.3 Latin America Recombinant Proteins Market Size by Type (2016-2027)
9.3 Latin America Recombinant Proteins Market Size by Application
9.3.1 Latin America Recombinant Proteins Market Size by Application (2016-2021)
9.3.2 Latin America Recombinant Proteins Market Size by Application (2022-2027)
9.3.3 Latin America Recombinant Proteins Market Size by Application (2016-2027)
9.4 Latin America Recombinant Proteins Market Size by Country
9.4.1 Latin America Recombinant Proteins Market Size by Country (2016-2021)
9.4.2 Latin America Recombinant Proteins Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Proteins Market Size (2016-2027)
10.2 Middle East & Africa Recombinant Proteins Market Size by Type
10.2.1 Middle East & Africa Recombinant Proteins Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recombinant Proteins Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recombinant Proteins Market Size by Type (2016-2027)
10.3 Middle East & Africa Recombinant Proteins Market Size by Application
10.3.1 Middle East & Africa Recombinant Proteins Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recombinant Proteins Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recombinant Proteins Market Size by Application (2016-2027)
10.4 Middle East & Africa Recombinant Proteins Market Size by Country
10.4.1 Middle East & Africa Recombinant Proteins Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recombinant Proteins Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abcam PLC
11.1.1 Abcam PLC Company Details
11.1.2 Abcam PLC Business Overview
11.1.3 Abcam PLC Recombinant Proteins Introduction
11.1.4 Abcam PLC Revenue in Recombinant Proteins Business (2016-2021)
11.1.5 Abcam PLC Recent Development
11.2 R&D Systems
11.2.1 R&D Systems Company Details
11.2.2 R&D Systems Business Overview
11.2.3 R&D Systems Recombinant Proteins Introduction
11.2.4 R&D Systems Revenue in Recombinant Proteins Business (2016-2021)
11.2.5 R&D Systems Recent Development
11.3 Miltenyi Biotec
11.3.1 Miltenyi Biotec Company Details
11.3.2 Miltenyi Biotec Business Overview
11.3.3 Miltenyi Biotec Recombinant Proteins Introduction
11.3.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2016-2021)
11.3.5 Miltenyi Biotec Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Recombinant Proteins Introduction
11.4.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Sigma Aldrich Company
11.5.1 Sigma Aldrich Company Company Details
11.5.2 Sigma Aldrich Company Business Overview
11.5.3 Sigma Aldrich Company Recombinant Proteins Introduction
11.5.4 Sigma Aldrich Company Revenue in Recombinant Proteins Business (2016-2021)
11.5.5 Sigma Aldrich Company Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Recombinant Proteins Introduction
11.6.4 GE Healthcare Revenue in Recombinant Proteins Business (2016-2021)
11.6.5 GE Healthcare Recent Development
11.7 Lonza
11.7.1 Lonza Company Details
11.7.2 Lonza Business Overview
11.7.3 Lonza Recombinant Proteins Introduction
11.7.4 Lonza Revenue in Recombinant Proteins Business (2016-2021)
11.7.5 Lonza Recent Development
11.8 Merck KGaA
11.8.1 Merck KGaA Company Details
11.8.2 Merck KGaA Business Overview
11.8.3 Merck KGaA Recombinant Proteins Introduction
11.8.4 Merck KGaA Revenue in Recombinant Proteins Business (2016-2021)
11.8.5 Merck KGaA Recent Development
11.9 ProSpec Tany TechnoGene
11.9.1 ProSpec Tany TechnoGene Company Details
11.9.2 ProSpec Tany TechnoGene Business Overview
11.9.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
11.9.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2016-2021)
11.9.5 ProSpec Tany TechnoGene Recent Development
11.10 Eurogentec (Kaneka Corporation)
11.10.1 Eurogentec (Kaneka Corporation) Company Details
11.10.2 Eurogentec (Kaneka Corporation) Business Overview
11.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Introduction
11.10.4 Eurogentec (Kaneka Corporation) Revenue in Recombinant Proteins Business (2016-2021)
11.10.5 Eurogentec (Kaneka Corporation) Recent Development
11.11 PeproTech
11.11.1 PeproTech Company Details
11.11.2 PeproTech Business Overview
11.11.3 PeproTech Recombinant Proteins Introduction
11.11.4 PeproTech Revenue in Recombinant Proteins Business (2016-2021)
11.11.5 PeproTech Recent Development
11.12 BPS Bioscience
11.12.1 BPS Bioscience Company Details
11.12.2 BPS Bioscience Business Overview
11.12.3 BPS Bioscience Recombinant Proteins Introduction
11.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2016-2021)
11.12.5 BPS Bioscience Recent Development
11.13 Reprocell
11.13.1 Reprocell Company Details
11.13.2 Reprocell Business Overview
11.13.3 Reprocell Recombinant Proteins Introduction
11.13.4 Reprocell Revenue in Recombinant Proteins Business (2016-2021)
11.13.5 Reprocell Recent Development
11.14 GenScript Biotech Corporation
11.14.1 GenScript Biotech Corporation Company Details
11.14.2 GenScript Biotech Corporation Business Overview
11.14.3 GenScript Biotech Corporation Recombinant Proteins Introduction
11.14.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2016-2021)
11.14.5 GenScript Biotech Corporation Recent Development
11.15 Abnova Corporation
11.15.1 Abnova Corporation Company Details
11.15.2 Abnova Corporation Business Overview
11.15.3 Abnova Corporation Recombinant Proteins Introduction
11.15.4 Abnova Corporation Revenue in Recombinant Proteins Business (2016-2021)
11.15.5 Abnova Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Recombinant Proteins Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormones
Table 3. Key Players of Growth Factors
Table 4. Key Players of Cytokines
Table 5. Key Players of Plasma Protein Factor
Table 6. Key Players of Recombinant Metabolic Enzymes
Table 7. Key Players of Immune Checkpoint Regulators
Table 8. Key Players of Others
Table 9. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Recombinant Proteins Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Recombinant Proteins Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Recombinant Proteins Market Share by Regions (2016-2021)
Table 13. Global Recombinant Proteins Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Recombinant Proteins Market Share by Regions (2022-2027)
Table 15. Recombinant Proteins Market Trends
Table 16. Recombinant Proteins Market Drivers
Table 17. Recombinant Proteins Market Challenges
Table 18. Recombinant Proteins Market Restraints
Table 19. Global Recombinant Proteins Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Recombinant Proteins Market Share by Players (2016-2021)
Table 21. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Proteins as of 2020)
Table 22. Ranking of Global Top Recombinant Proteins Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Recombinant Proteins Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Recombinant Proteins Product Solution and Service
Table 26. Date of Enter into Recombinant Proteins Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Recombinant Proteins Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Recombinant Proteins Revenue Market Share by Type (2016-2021)
Table 30. Global Recombinant Proteins Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Recombinant Proteins Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Recombinant Proteins Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Recombinant Proteins Revenue Market Share by Application (2016-2021)
Table 34. Global Recombinant Proteins Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Recombinant Proteins Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Recombinant Proteins Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Recombinant Proteins Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Recombinant Proteins Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Recombinant Proteins Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Recombinant Proteins Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Recombinant Proteins Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Recombinant Proteins Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Recombinant Proteins Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Recombinant Proteins Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Recombinant Proteins Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Recombinant Proteins Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Recombinant Proteins Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Recombinant Proteins Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Recombinant Proteins Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Recombinant Proteins Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Recombinant Proteins Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Recombinant Proteins Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Recombinant Proteins Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Recombinant Proteins Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Recombinant Proteins Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Recombinant Proteins Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Recombinant Proteins Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Recombinant Proteins Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Recombinant Proteins Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Recombinant Proteins Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Recombinant Proteins Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Recombinant Proteins Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Recombinant Proteins Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Recombinant Proteins Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Recombinant Proteins Market Size by Country (2022-2027) & (US$ Million)
Table 66. Abcam PLC Company Details
Table 67. Abcam PLC Business Overview
Table 68. Abcam PLC Recombinant Proteins Product
Table 69. Abcam PLC Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 70. Abcam PLC Recent Development
Table 71. R&D Systems Company Details
Table 72. R&D Systems Business Overview
Table 73. R&D Systems Recombinant Proteins Product
Table 74. R&D Systems Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 75. R&D Systems Recent Development
Table 76. Miltenyi Biotec Company Details
Table 77. Miltenyi Biotec Business Overview
Table 78. Miltenyi Biotec Recombinant Proteins Product
Table 79. Miltenyi Biotec Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 80. Miltenyi Biotec Recent Development
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Recombinant Proteins Product
Table 84. Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 85. Thermo Fisher Scientific Recent Development
Table 86. Sigma Aldrich Company Company Details
Table 87. Sigma Aldrich Company Business Overview
Table 88. Sigma Aldrich Company Recombinant Proteins Product
Table 89. Sigma Aldrich Company Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 90. Sigma Aldrich Company Recent Development
Table 91. GE Healthcare Company Details
Table 92. GE Healthcare Business Overview
Table 93. GE Healthcare Recombinant Proteins Product
Table 94. GE Healthcare Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 95. GE Healthcare Recent Development
Table 96. Lonza Company Details
Table 97. Lonza Business Overview
Table 98. Lonza Recombinant Proteins Product
Table 99. Lonza Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 100. Lonza Recent Development
Table 101. Merck KGaA Company Details
Table 102. Merck KGaA Business Overview
Table 103. Merck KGaA Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 104. Merck KGaA Recent Development
Table 105. ProSpec Tany TechnoGene Company Details
Table 106. ProSpec Tany TechnoGene Business Overview
Table 107. ProSpec Tany TechnoGene Recombinant Proteins Product
Table 108. ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 109. ProSpec Tany TechnoGene Recent Development
Table 110. Eurogentec (Kaneka Corporation) Company Details
Table 111. Eurogentec (Kaneka Corporation) Business Overview
Table 112. Eurogentec (Kaneka Corporation) Recombinant Proteins Product
Table 113. Eurogentec (Kaneka Corporation) Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 114. Eurogentec (Kaneka Corporation) Recent Development
Table 115. PeproTech Company Details
Table 116. PeproTech Business Overview
Table 117. PeproTech Recombinant Proteins Product
Table 118. PeproTech Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 119. PeproTech Recent Development
Table 120. BPS Bioscience Company Details
Table 121. BPS Bioscience Business Overview
Table 122. BPS Bioscience Recombinant Proteins Product
Table 123. BPS Bioscience Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 124. BPS Bioscience Recent Development
Table 125. Reprocell Company Details
Table 126. Reprocell Business Overview
Table 127. Reprocell Recombinant Proteins Product
Table 128. Reprocell Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 129. Reprocell Recent Development
Table 130. GenScript Biotech Corporation Company Details
Table 131. GenScript Biotech Corporation Business Overview
Table 132. GenScript Biotech Corporation Recombinant Proteins Product
Table 133. GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 134. GenScript Biotech Corporation Recent Development
Table 135. Abnova Corporation Company Details
Table 136. Abnova Corporation Business Overview
Table 137. Abnova Corporation Recombinant Proteins Product
Table 138. Abnova Corporation Revenue in Recombinant Proteins Business (2016-2021) & (US$ Million)
Table 139. Abnova Corporation Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Proteins Market Share by Type: 2020 VS 2027
Figure 2. Hormones Features
Figure 3. Growth Factors Features
Figure 4. Cytokines Features
Figure 5. Plasma Protein Factor Features
Figure 6. Recombinant Metabolic Enzymes Features
Figure 7. Immune Checkpoint Regulators Features
Figure 8. Others Features
Figure 9. Global Recombinant Proteins Market Share by Application: 2020 VS 2027
Figure 10. Biopharmaceutical Companies Case Studies
Figure 11. Academic and Research Institutes Case Studies
Figure 12. Contract Research Organizations Case Studies
Figure 13. Recombinant Proteins Report Years Considered
Figure 14. Global Recombinant Proteins Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Recombinant Proteins Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Recombinant Proteins Market Share by Regions: 2020 VS 2027
Figure 17. Global Recombinant Proteins Market Share by Regions (2022-2027)
Figure 18. Global Recombinant Proteins Market Share by Players in 2020
Figure 19. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Proteins as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Recombinant Proteins Revenue in 2020
Figure 21. Global Recombinant Proteins Revenue Market Share by Type (2016-2021)
Figure 22. Global Recombinant Proteins Revenue Market Share by Type (2022-2027)
Figure 23. North America Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Recombinant Proteins Market Share by Type (2016-2027)
Figure 25. North America Recombinant Proteins Market Share by Application (2016-2027)
Figure 26. North America Recombinant Proteins Market Share by Country (2016-2027)
Figure 27. United States Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Recombinant Proteins Market Share by Type (2016-2027)
Figure 31. Europe Recombinant Proteins Market Share by Application (2016-2027)
Figure 32. Europe Recombinant Proteins Market Share by Country (2016-2027)
Figure 33. Germany Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Recombinant Proteins Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Recombinant Proteins Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Recombinant Proteins Market Share by Region (2016-2027)
Figure 43. China Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Recombinant Proteins Market Share by Type (2016-2027)
Figure 51. Latin America Recombinant Proteins Market Share by Application (2016-2027)
Figure 52. Latin America Recombinant Proteins Market Share by Country (2016-2027)
Figure 53. Mexico Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Recombinant Proteins Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Recombinant Proteins Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Recombinant Proteins Market Share by Country (2016-2027)
Figure 59. Turkey Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Recombinant Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abcam PLC Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 63. R&D Systems Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 64. Miltenyi Biotec Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 66. Sigma Aldrich Company Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 67. GE Healthcare Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 68. Lonza Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 69. Merck KGaA Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 70. ProSpec Tany TechnoGene Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 71. Eurogentec (Kaneka Corporation) Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 72. PeproTech Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 73. BPS Bioscience Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 74. Reprocell Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 75. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 76. Abnova Corporation Revenue Growth Rate in Recombinant Proteins Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の組換え治療用抗体＆タンパク質市場規模・現状・予測（2021年-2027年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…- 世界の組換え非グリコシル化タンパク質バイオシミラー市場規模・現状・予測（2021年-2027年） Recombinant non-glycosylated proteins include human growth hormone, granulocyte colony-stimulating factor, interferons, and insulin. The statistic scope in this report is Recombinant non-glycosylated proteins biosimilars. Market Analysis and Insights: Global Recombinant Non-Glycosylated Proteins Bio…
- 世界の抗血友病因子（組換え）市場規模・現状・予測（2021年-2027年） Antihemophilic factor is a naturally occurring protein in the blood that helps blood to clot. Market Analysis and Insights: Global Antihemophilic Factor (Recombinant) Market The global Antihemophilic Factor (Recombinant) market size is projected to reach US$ XX million by 2027, from US$ XX million i…
- 世界の組換えタンパク質治療薬市場規模・現状・予測（2021年-2027年） In the 1970s, recombinant DNA technology hardly opened a new era of pharmaceutical biotechnology. Therefore, the definition of protein therapeutics covers drugs that are structurally proteins or peptides, as well as drugs obtained through recombinant DNA technology. Market Analysis and Insights: Glo…
- 世界の組換えタンパク質市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Recombinant Protein Market The global Recombinant Protein market size is projected to reach US$ 1062 million by 2026, from US$ 612 million in 2019, at a CAGR of 8.1% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…